Dwaipayan Chatterjee on Muck Rack

Dwaipayan Chatterjee

As seen in: Market Realist
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dwaipayan

Contact Dwaipayan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Understanding cloud systems structure and organization using a machine’s self-learning approach

|
By Dwaipayan Chatterjee, Susanne Crewell, Claudia Acquistapace, Hartwig Deneke
| ametsoc.org
Share Link Copy this link, or click below to email it to a friend Email this content or copy the link directly: The link was not copied. Your current browser may not support copying via this button.
Open in Who Shared View Duplicates (13) Issue with article?

This Collaboration Is Expected to Boost Merck’s Long-Term Growth

|
By Daniel Collins, Dwaipayan Chatterjee
| Market Realist
Taking Merck & Company's Pulse in the Wake of Its First Quarter Merck & Company (MRK) has entered into a global strategic oncology collaboration with Eisai for the worldwide codevelopment and co-commercialization of Eisai’s Lenvima. Merck and Eisai will jointly develop and commercialize Lenvima as a monotherapy and in combination with Keytruda.
Open in Who Shared Issue with article?

A Brief Overview of Merck’s First-Quarter Performance

|
By Daniel Collins, Dwaipayan Chatterjee
| Market Realist
Taking Merck & Company's Pulse in the Wake of Its First Quarter Merck & Company (MRK) reported revenue of $10.0 billion in Q1 2018 compared to $9.4 billion in Q1 2017, which reflected a ~6% rise YoY (year-over-year) and a ~4% fall sequentially. In Q1 2018, Merck saw a ~2% positive impact from foreign exchange. Keytruda and Gardasil primarily pushed the company’s revenue growth in the first quarter.
Open in Who Shared Issue with article?
See all 106 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Dwaipayan

Contact Dwaipayan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified